Novo raises targets on Victoza, insulin demand

[Northerner]

Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations, sending its shares to an all-time high.

The world's biggest insulin producer also revealed good results from a clinical trial testing a new combination of two diabetes medicines, cementing its dominant position in a growing segment as the number of diabetes sufferers worldwide rises from its current level of more than 300 million.

http://uk.reuters.com/article/2012/08/09/us-novonordisk-idUKBRE8780D220120809

 

[Vicsetter]

IDegLira now in phase 3 testing sounds interesting, much the sort of thing I am on Victoza and insulin.

 

[linda metcalfe]

insulin

Hi Vicsetter
Ive never heard of these insulins

 

[Vicsetter]

Victoza isn't an insulin, it's similar to Byetta.